AI assistant
USCOM LIMITED — Board/Management Information 2011
Jul 14, 2011
65979_rns_2011-07-14_3d01c9ce-2e03-4865-a757-82b09159f42c.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
Uscom appoints Global SVP of Sales
Friday 15th of July 2011: Uscom (ASX code: UCM).
Uscom announces the appointment of Joe Trygar as Senior Vice President to head its Global Sales. Mr. Trygar will be based in North America and will be responsible for developing and executing Uscom’s Global Sales strategies and achieve significant sales revenues across its global distribution network.
Mr. Trygar joins Uscom with more than 30 years experience in the medical instrumentation and automation markets including research, engineering, strategic development, & global distribution.
Most recently, Mr. Trygar served as President and founder of Dossette, a medical equipment manufacturing, development, and sales consulting business. Mr. Trygar is also a successful entrepreneur who has founded and successfully sold several businesses, and a sales leader who has delivered dramatic successes for several fortune 500 companies.
His track record of exponentially growing sales in the medical device markets both in North American & globally includes a sound knowledge of the cardiac monitoring sector. He has demonstrated an ability to accelerate strategic & tactical plans, & deliver exponential growth for operations in intensely competitive markets.
Executive Chairman of Uscom, Phil Kiely said, “As we continue building a global network of distributors we need to ensure that they generate sales results with our device which exceeds even our own expectations. Importantly for Uscom, Joe is recognized for his ability to work in close quarters with the sales reps of distributors, to distill complex issues to fundamentals, create blueprints for growth, & implement systems & initiatives to grow sales revenues, profitability, sustainability, competitive advantage, & high close ratios.”
Mr. Kiely said,” We have barely scratched the surface of the US$2.8b revenues generated in the cardiac patient monitor market and Mr. Trygar’s pivotal appointment will help Uscom secure its fair share of this rapidly expanding marketplace.
About Uscom
Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India, Australia & New Zealand. China and SE Asia.
Uscom Contacts Phil Kiely Executive Chairman [email protected]
Daniel Fah Company Secretary [email protected]